Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 2 |
2020 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Blocking AMPK signalling to acetyl-CoA carboxylase increases cisplatin-induced acute kidney injury and suppresses the benefit of metformin.
Biomed Pharmacother. 2022 Sep;153:113377. doi: 10.1016/j.biopha.2022.113377. Epub 2022 Jul 12.
Biomed Pharmacother. 2022.
PMID: 36076520
Free article.
Mutation of regulatory phosphorylation sites in PFKFB2 worsens renal fibrosis.
Lee M, Harley G, Katerelos M, Gleich K, Sullivan MA, Laskowski A, Coughlan M, Fraser SA, Mount PF, Power DA.
Lee M, et al. Among authors: harley g.
Sci Rep. 2020 Sep 3;10(1):14531. doi: 10.1038/s41598-020-71475-z.
Sci Rep. 2020.
PMID: 32884050
Free PMC article.
Item in Clipboard
Mutation of regulatory phosphorylation sites in PFKFB2 does not affect the anti-fibrotic effect of metformin in the kidney.
Harley G, Katerelos M, Gleich K, Lee M, Mount PF, Power DA.
Harley G, et al.
PLoS One. 2023 Feb 9;18(2):e0280792. doi: 10.1371/journal.pone.0280792. eCollection 2023.
PLoS One. 2023.
PMID: 36757995
Free PMC article.
Item in Clipboard
Lifetime end-stage kidney disease risk estimation in living kidney donor candidates remains a challenge.
Lee D, Whitlam JB, Cook N, Manzoor M, Harley G, Choy SW, McMahon LP, Roberts MA.
Lee D, et al. Among authors: harley g.
Transpl Int. 2018 Jan;31(1):118-120. doi: 10.1111/tri.13080. Epub 2017 Oct 27.
Transpl Int. 2018.
PMID: 29024051
Free article.
No abstract available.
Item in Clipboard
Use of a new end-stage kidney disease risk calculator in the Kidney Disease Improving Global Outcomes guideline to evaluate the impact of different living kidney donor candidate assessments.
Lee D, Manzoor M, Harley G, Whitlam J, Cook N, Choy SW, Sandiford M, Gibson C, McMahon LP, Roberts MA.
Lee D, et al. Among authors: harley g.
Nephrology (Carlton). 2018 Jul;23(7):616-624. doi: 10.1111/nep.13074.
Nephrology (Carlton). 2018.
PMID: 28544308
Item in Clipboard
The AMPK activator ATX-304 alters cellular metabolism to protect against cisplatin-induced acute kidney injury.
Katerelos M, Gleich K, Harley G, Loh K, Oakhill JS, Kemp BE, de Souza DP, Narayana VK, Coughlan MT, Laskowski A, Ling NXY, Murray-Segal L, Brink R, Lee M, Power DA, Mount PF.
Katerelos M, et al. Among authors: harley g.
Biomed Pharmacother. 2024 May 14;175:116730. doi: 10.1016/j.biopha.2024.116730. Online ahead of print.
Biomed Pharmacother. 2024.
PMID: 38749175
Free article.
Item in Clipboard
Cite
Cite